10 insiders reported 52 Form 4 transactions for Rezolute, Inc. (RZLT) over the past 18 months (most recent 2026-07-07). Recent activity: Elam Nevan C (CEO) Sell 8,004 shares, Evans Daron (CFO) Sell 3,062 shares, ROBERTS BRIAN KENNETH (Chief Medical Officer) Sell 3,062 shares, Evans Daron (CFO) Buy 10,000 shares, Elam Nevan C (CEO) Sell 27,618 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-07 | Elam Nevan C | CEO | Sell | 8,004 | $39,940 |
| 2026-07-07 | Evans Daron | CFO | Sell | 3,062 | $15,279 |
| 2026-07-07 | ROBERTS BRIAN KENNETH | Chief Medical Officer | Sell | 3,062 | $15,279 |
| 2026-03-31 | Evans Daron | CFO | Buy | 10,000 | $28,500 |
| 2026-03-04 | Elam Nevan C | CEO | Sell | 27,618 | $82,578 |
| 2026-03-04 | ROBERTS BRIAN KENNETH | Chief Medical Officer | Sell | 11,439 | $34,203 |
| 2026-03-04 | Evans Daron | CFO | Sell | 11,438 | $34,200 |
| 2025-12-17 | Hogenhuis Wladimir | Director | Buy | 5,650 | $9,548 |
| 2025-12-17 | ROBERTS BRIAN KENNETH | Chief Medical Officer | Buy | 28,000 | $47,600 |
| 2025-12-15 | Evans Daron | CFO | Buy | 40,000 | $70,800 |
| 2025-12-15 | Karnawat Sunil Ratilal | Chief Commercial Officer | Buy | 12,000 | $19,440 |
| 2025-12-15 | Karnawat Sunil Ratilal | Chief Commercial Officer | Buy | 100 | $160 |
| 2025-12-15 | Elam Nevan C | CEO | Buy | 32,000 | $50,880 |
| 2025-12-15 | Evans Daron | CFO | Buy | 2,500 | $4,475 |
| 2025-12-15 | Evans Daron | CFO | Buy | 2,500 | $4,475 |
| 2025-11-21 | Labrucherie Gil M | Director | Buy | 21,000 | $0 |
| 2025-11-21 | Karnawat Sunil Ratilal | Chief Commercial Officer | Buy | 32,000 | $0 |
| 2025-11-21 | Evans Daron | CFO | Buy | 107,000 | $0 |
| 2025-11-21 | Harris Erik | Director | Buy | 21,000 | $0 |
| 2025-11-21 | Kim Young-Jin | Director | Buy | 21,000 | $0 |
| 2025-11-21 | FAUCHET PHILIPPE | Director | Buy | 21,000 | $0 |
| 2025-11-21 | KREHER NERISSA | Director | Buy | 21,000 | $0 |
| 2025-11-21 | Elam Nevan C | CEO | Buy | 317,000 | $0 |
| 2025-11-21 | Hogenhuis Wladimir | Director | Buy | 21,000 | $0 |
| 2025-11-21 | ROBERTS BRIAN KENNETH | Chief Medical Officer | Buy | 123,000 | $0 |
Source: SEC Form 4 filings · as of 2026-07-07